According to our (Global Info Research) latest study, the global Biopharmaceutical Logistic market size was valued at US$ 46320 million in 2025 and is forecast to a readjusted size of US$ 77916 million by 2032 with a CAGR of 7.7% during review period.
Biopharmaceutical Logistics refers to a specialized logistics system that manages temperature-controlled transportation, storage, and supply chain coordination throughout the entire lifecycle of biopharmaceutical products, including development, manufacturing, distribution, and clinical use. Its primary objective is to ensure the integrity, safety, and regulatory compliance of high-value biologics such as vaccines, monoclonal antibodies, and cell and gene therapies. This system relies on advanced cold chain technologies (ranging from 2–8°C to ultra-low temperatures such as -80°C), real-time monitoring systems, and global distribution networks to enable high-standard delivery from production sites to healthcare providers. With the rapid growth of the biopharmaceutical industry and increasing complexity of global supply chains, biopharmaceutical logistics has evolved from a traditional transportation function into a critical infrastructure integrating technology, services, and compliance, playing a vital role in enabling commercialization and globalization of innovative therapies.The average gross profit margin of this product is 35%.
Driven by the rapid expansion of the global biopharmaceutical industry and the accelerated commercialization of innovative therapies, biopharmaceutical logistics is experiencing strong structural growth. Products such as vaccines, monoclonal antibodies, and cell and gene therapies require strict temperature control and handling conditions, transforming cold chain logistics from a supporting function into a core capability. Governments worldwide are strengthening regulatory frameworks for pharmaceutical distribution, promoting standardization and compliance. According to corporate disclosures and financial analyses, major pharmaceutical companies are expanding globally, significantly increasing demand for high-quality logistics services. Meanwhile, the integration of digital technologies and IoT is enhancing visibility and traceability across the supply chain, further elevating industry value.Despite strong growth prospects, the industry faces several challenges. Biopharmaceutical products are highly sensitive to temperature variations, and any deviation during transportation may compromise product integrity, placing stringent demands on logistics providers. Cross-border transportation involves complex regulatory compliance across multiple jurisdictions, increasing operational complexity and costs. In addition, cold chain infrastructure remains underdeveloped in certain emerging markets, limiting industry expansion. Supply chain disruptions and unforeseen global events can also impact logistics efficiency and reliability Downstream demand is shifting toward higher-value and more globalized applications. The increasing share of innovative biologics is expanding logistics requirements from traditional vaccines to advanced therapies such as cell and gene treatments. The globalization of clinical trials is driving demand for small-batch, high-frequency shipments. Healthcare providers and pharmaceutical companies are raising expectations from simple delivery to full-process quality management, pushing logistics providers to evolve into integrated solution partners. Furthermore, the rise of home-based treatment and decentralized healthcare models is reshaping last-mile delivery requirements.Upstream components primarily include cold chain equipment, temperature-controlled packaging materials, and monitoring technologies. High-performance insulated containers, phase change materials, and dry ice directly impact temperature control performance, while sensors and data loggers ensure traceability throughout the logistics process. With advancements in material science and smart technologies, upstream development is moving toward higher efficiency, intelligence, and sustainability. However, advanced equipment and critical materials still involve significant technological barriers, emphasizing the importance of supply chain reliability.
This report is a detailed and comprehensive analysis for global Biopharmaceutical Logistic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biopharmaceutical Logistic market size and forecasts, in consumption value ($ Million), 2021-2032
Global Biopharmaceutical Logistic market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Biopharmaceutical Logistic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Biopharmaceutical Logistic market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biopharmaceutical Logistic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biopharmaceutical Logistic market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Deutsche Post DHL, Kuehne + Nagel, UPS, McKesson, FedEx, Nippon Express, Cencora, SF Express, CMA CGM, DSV, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biopharmaceutical Logistic market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cold Chain Logistics
Non-cold Chain Logistics
Market segment by Function
Warehousing
Transportation
Packaging
Other
Market segment by Product
Freight
Parcel
Market segment by Application
Ground Shipping
Sea Shipping
Air Shipping
Market segment by players, this report covers
Deutsche Post DHL
Kuehne + Nagel
UPS
McKesson
FedEx
Nippon Express
Cencora
SF Express
CMA CGM
DSV
Kerry Logistics
CH Robinson
Air Canada Cargo
Sinopharm Group
Shanghai Pharma
CR Pharma
Jointown Logistics
BioLife Solutions
OOCL Logistics
Shengsheng Pharmaceutical Cold Chain
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biopharmaceutical Logistic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biopharmaceutical Logistic, with revenue, gross margin, and global market share of Biopharmaceutical Logistic from 2021 to 2026.
Chapter 3, the Biopharmaceutical Logistic competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biopharmaceutical Logistic market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biopharmaceutical Logistic.
Chapter 13, to describe Biopharmaceutical Logistic research findings and conclusion.
Summary:
Get latest Market Research Reports on Biopharmaceutical Logistic. Industry analysis & Market Report on Biopharmaceutical Logistic is a syndicated market report, published as Global Biopharmaceutical Logistic Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Biopharmaceutical Logistic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.